Post job

Array BioPharma CEO and executives

Executive Summary. Based on our data team's research, Ron Squarer is the Array BioPharma's CEO. Array BioPharma has 298 employees, of which 20 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Array BioPharma executive team is 35% female and 65% male.
  • 63% of the management team is White.
  • 12% of Array BioPharma management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Array BioPharma?
Share your experience

Rate Array BioPharma's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Ron Squarer

CEO

Ron Squarer's LinkedIn

Ron Squarer serves as Chairman and Executive Advisor at ADC Therapeutics SA (NYSE: ADCT) and directly supported the May 2020 company IPO. Mr. Squarer served as Chief Executive Officer and a member of the Array Biopharma Board of Directors from April 2012 through August 2019 when Pfizer Inc. acquired the company for $11.8 billion following the successful launch of the cancer treatments Braftovi® and Mektovi®. During his tenure, the company’s valuation grew ~40-fold through execution across research, development, and commercialization focused in the Oncology area. Array Biopharma’s research team is recognized for having invented Vitrakvi®/larotrectinib/TRK, Koselugo®/selumetinib/MEK, Tukysa®/tucatinib/HER2, ipatasertib/AKT, selpercatinib/RET, and MRTX849/KRAS-G12C among other molecules. Mr. Squarer has extensive commercial, development, research prioritization, and executive leadership expertise from a career spanning more than two decades in the biopharmaceutical industry. Before joining Array, Mr. Squarer held positions of increasing responsibility with Hospira, Inc., a global pharmaceutical and medical device company. In his last role there, as Senior Vice President and Chief Commercial Officer, he was responsible for delivering $4 billion in annual revenue. Mr. Squarer joined Hospira from Mayne Pharma, where he served as Senior Vice President, Global Corporate and Business Development when Mayne was sold to Hospira in 2007 for over $2 billion. Before Mayne Pharma, Mr. Squarer held leadership roles at both Pfizer, Inc. (including in Oncology), and SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) in the U.S. and Europe and currently serves as a member of the Board of Directors of Deciphera Inc. (NASDAQ: DCPH) and Travere Therapeutics Inc. (NASDAQ: TVTX) Mr. Squarer earned an MBA from the Kellogg School of Management, Northwestern University, and a bachelor’s degree in biochemistry from the University of California, Berkeley.

Kevin Koch

Founder

Tony Piscopio

Founder

David L Snitman

COO & Vice President

David L Snitman's LinkedIn

Dr. Snitman is a Co-Founder of Array and has served as Chief Operating Officer, Vice President of Business Development, and a member of the Board of Directors since May 1998. Prior to forming Array, Dr. Snitman held various positions with Amgen Inc. since 1981, including Associate Director, New Products and Technology and Manager of Amgen's Boulder research facility. Dr. Snitman received a B.S. in chemistry from Northeastern University and obtained a Ph.D. in the synthesis of natural products from the University of Colorado. He was an NIH Postdoctoral Fellow at the Massachusetts Institute of Technology.

Nicholas Saccomano

Chief Scientific Officer

Dr. Nick Saccomano is a Chief Scientific Officer at ARRAY BIOPHARMA INC and is based in United States.

Andrew Robbins

COO

Angie Lyle

Chief Operating Officer

Angie Lyle's LinkedIn

Angie Lyle is a Chief Operating Officer at ARRAY BIOPHARMA INC and is based in Fayetteville, North Carolina.

Gwen Fyfe

Board Member

Jason Haddock

CFO

Joe Ehrline

Chief Revenue Officer

Joe Ehrline's LinkedIn

Joe is the Vice President of Sales at Saama Technologies, responsible for Saama’s commercial development in the Life Sciences industry. He drives overall sales and customer success, building the infrastructure, growing the team and enchaining Saama’s position in the industry. Joe brings a wealth of sales acumen and customer focus to Saama from his 25+ years in sales and sales leadership, mostly in Life Sciences. Prior to joining Saama, Joe spent over 6 years working with Medidata Solutions, a leader in eClnical development software, managing teams for both direct sales into Pharmaceutical, Biotech and Medical Device companies, as well as the large Contract Research Organization (CRO) space. While there he consistently achieved stellar sales results, helping to grow the business and increase customer satisfaction and retention rates. Prior to Medidata, Joe was Vice President of Sales at Sparta Systems, a leader in Quality Management Systems in Life Sciences, where he transformed the sales team and built winning teams that accounted for significant company growth. Joe graduated from Villanova University undergraduate business school and later earned an MBA with honors from Saint Joseph’s University. Joe thoroughly enjoys his three college-aged children. He’s personally involved in volunteer and community service with various organizations, including serving on the Board of Trustees for The Boys & Girls Club of Camden NJ. He’s an avid skier, fitness enthusiast, and Harley Davidson motorcycle rider. Joe spends most summer weekends at the NJ beach enjoying outdoor activities.

Do you work at Array BioPharma?

Does the leadership team provide a clear direction for Array BioPharma?

Array BioPharma jobs

Array BioPharma founders

Name & TitleBio
Kevin Koch

Founder

Tony Piscopio

Founder

Array BioPharma board members

Name & TitleBio
Gwen Fyfe

Board Member

Richard See

Board Member

Array BioPharma leadership demographics

Array BioPharma gender distribution in management team

  • The Array BioPharma executive team is 35% female and 65% male.
  • Array BioPharma is 40% female and 60% male company-wide.
Male
Male
65%
Company-wide: 60%
Female
Female
35%
Company-wide: 40%

Array BioPharma executives by race

Management Team:
  • The most common ethnicity among Array BioPharma executive officers is White.
  • 63% of the management team is White.
  • 12% of Array BioPharma's management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 70% of employees are White.
  • 12% of employees are Hispanic or Latino.
  • 8% of employees are Asian.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Array BioPharma jobs nearby

Array BioPharma executives FAQs

Zippia gives an in-depth look into the details of Array BioPharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Array BioPharma. The employee data is based on information from people who have self-reported their past or current employments at Array BioPharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Array BioPharma. The data presented on this page does not represent the view of Array BioPharma and its employees or that of Zippia.

Array BioPharma may also be known as or be related to ARRAY BIOPHARMA INC, Array BioPharma, Array BioPharma Inc. and Array Biopharma Inc.